Metastatic sites of baseline as predictors in recurrent or metastatic nasopharyngeal carinoma treated with PD-L1 inhibitor: a secondary analysis of multicenter, single-arm, phase II study (KL-A167)

Abstract Background Immune checkpoint inhibitors (ICIs) show optimal treatment effects on recurrent or metastatic nasopharyngeal carcinoma(R/M NPC). Nonetheless, whether metastatic sites impact ICIs efficacy remains unclear. Methods We performed a secondary analysis of R/M NPC patients treated with...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yuantai Li, Yu Min, Zhigong Wei, Zheran Liu, Yiyan Pei, Yujie Yang, Kun Gao, Ge Song, Shihong Xu, Shuangshuang He, Junyou Ge, Yan Qing, Youneng Wei, Ping Ai, Ye Chen, Xingchen Peng
Format:	Artigo
Idioma:	Inglês
Publicat:	Springer 2025-01-01
Col·lecció:	Cancer Immunology, Immunotherapy
Matèries:	Metastatic sites Nasopharyngeal carcinoma Anti-PD-L1 Survival
Accés en línia:	https://doi.org/10.1007/s00262-024-03905-0
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!